RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024

At this year’s Academy of Managed Care Pharmacy (AMCP) Annual Meeting, more than 4,000 industry leaders, health care professionals and researchers gathered in New Orleans to advance the field of managed care pharmacy. In addition to having a booth presence at the event, Prime Therapeutics/Magellan Rx Management (Prime/MRx)’s experts presented eight research studies that evaluated real-world drug utilization, managed care pharmacy programs and associated costs of care for a variety of health conditions. Four of these posters won awards. Our experts also shared additional insights during five educational sessions. Here is a recap of stories, perspectives and news coverage from AMCP 2024.

Stories 

Prime/MRx resident wins AMCP Foundation Best Poster Award
Ai Quynh Nguyen, PharmD, was recently recognized for her research on opioid-prescribing patterns and outcomes
Read more »

Perspectives 

LISTEN NOW: Live at AMCP Annual 2024 – Digging into managed care pharmacy insights | Pharmacy Friends podcast
In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)’s 2024 Annual Meeting in New Orleans
Listen now »

AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients
Read more »

AMCP 2024: Behind the research with YuQian Liu 
Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier
Read more »

AMCP 2024: Behind the research with Prerak Parikh 
Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars
Read more »

AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick
Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting
Read more »

In the News

AMCP 2024: Key Takeaways From Leading Speakers
American Journal of Managed Care (AJMC): Session speakers at the Academy of Managed Care Pharmacy (AMCP) 2024 annual conference share their favorite parts of the event and the key takeaways they will leave the conference with
Read more »

Award-Winning Poster Presentations From AMCP 2024
American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality
Read more »

Treating Obesity Without Diabetes: Real-World Cost-Effectiveness of GLP-1 Agents  
Academy of Managed Care Pharmacy (AMCP)
Read more »

Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
American Journal of Managed Care (AJMC): Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments
Read more »

Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes
Read more »

Dr. YuQian Liu Investigates the Future Benefits of Cell, Gene Therapies Using Real-World Data
American Journal of Managed Care (AJMC): YuQian Liu, PharmD, Magellan Rx Management, explores the current space of cell and gene therapies based on real-world data and potential emerging therapies in the future, while expanding upon long-term efficacy concerns
Read more »

Multiple Sclerosis Generics Switching Program Saves Millions
Specialty Pharmacy Continuum: A program in which managed care pharmacists reached out to healthcare providers in 2023 to advise them of potential cost savings that could accrue by switching their patients with multiple sclerosis (MS) from branded to generic therapies has generated significant savings
Read more »

Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024
Read more »